Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Vegan growth stock hits new low despite continued expansion

 Trevor Abes Trevor Abes , The Market Online
0 Comments| November 7, 2024

{{labelSign}}  Favorites
{{errorMessage}}

  • Else Nutrition (TSX:BABY), a vegan growth stock, has fallen to an all-time-low as the company continues to expand its product suite with major retailers
  • The company posted robust revenue growth and lower operating expenses in Q2 2024 and will release Q3 results on November 14
  • Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults across the world with a specialty in soy-free and dairy-free alternatives
  • Else Nutrition stock is unchanged trading at an all-time-low of C$0.03 per share as of 11:02 am ET, saddling investors with a 91.89 per cent loss year-over-year

Else Nutrition (TSX:BABY), a vegan growth stock, has fallen to an all-time-low as the company continues to expand its product suite with major retailers.

The company’s most recent milestone is a 12-week pilot program for its kids ready-to-drink shakes with a wholesale retailer previously profiled on Stockhouse.

Initiated in November across 11 Canadian locations – including high-visibility endcap displays and product sampling demos – the program aims to validate a nationwide rollout in over 100 locations in 2025.

The news follows strong growth and lower operating expenses in Q2 2024, as well as recent expansions with a top global retailer, the United States Navy Exchange and a leading independent supermarket, adding to the company’s over 10x growth in North American brick-and-mortar locations to over 13,000 since January 2022.

Else’s financial results for Q3 are expected to hit the wire on November 14.

Leadership insights

“We’re thrilled to partner with this well-known wholesale retailer to provide families with easy access to clean, nutritious and delicious options for their children,” Hamutal Yitzhak, co-founder and chief executive officer of Else Nutrition, said in a statement. “This 12-week pilot is a unique opportunity positioning us for potential expansion across Canada, as well as entry into the United States. We’re looking forward to building on this momentum as we continue our strategic expansion and provide better alternatives to families globally.”

About Else Nutrition Holdings

Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults across the world with a specialty in soy-free and dairy-free alternatives. Its products include cereals, shake mixes and ready-to-drink shakes.

Else Nutrition stock (TSX:BABY) is unchanged trading at an all-time-low of C$0.03 per share as of 11:02 am ET. The stock has given back 91.89 per cent year-over-year.

Join the discussion: Find out what everybody’s saying about this vegan growth stock on the Else Nutrition Holdings Inc. Bullboard and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: Adobe Stock)




{{labelSign}}  Favorites
{{errorMessage}}


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company